Literature DB >> 10849957

Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp--a molecular-epidemiological study.

K P Hunfeld1, C Schmidt, B Krackhardt, H G Posselt, J Bargon, Y Yahaf, V Schäfer, V Brade, T A Wichelhaus.   

Abstract

OBJECTIVE: A study on the molecular epidemiology of Pseudomonas aeruginosa in patients with cystic fibrosis (CF) from Germany (N = 18) and Israel (N = 12) is presented. The aim is to provide an answer to the question as to whether or not social contact outside the hospital environment involves a potential risk for person-to-person spread of this pathogen.
METHODS: Sputa from German and Israeli patients were obtained while these were attending a holiday camp in Israel. The sputum samples were analysed with regard to Pseudomonas aeruginosa. Strains dissimilar in macroscopic appearance and/or antibiotic resistance patterns were genotyped using pulsed-field gel electrophoresis after digestion of genomic DNA with restriction endonuclease Spel. The genetic polymorphism of DNA fragment patterns of all strains (N = 146) was studied for their overall relatedness using a fingerprint software system.
RESULTS: Most of the German patients (77.7%) were colonised persistently by a unique clonal type during the four-week screening period. Isolates obtained from Israeli patients displayed a very close clonal relationship and a higher antibiotic resistance as a result of preceding epidemic spread of certain clones before the camp. Additionally, isolates showing identical PFGE patterns were demonstrated once in a single male Israeli patient and in one female German patient, suggesting previous cross-colonisation.
CONCLUSION: The occurrence of person-to-person spread through social contact in patients with CF is supported by our findings, but remains a rare event outside the hospital environment, provided appropriate hygienic measures are applied.

Entities:  

Mesh:

Year:  2000        PMID: 10849957

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  11 in total

1.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.

Authors:  David Armstrong; Scott Bell; Michael Robinson; Peter Bye; Barbara Rose; Colin Harbour; Crystal Lee; Helen Service; Michael Nissen; Melanie Syrmis; Claire Wainwright
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 3.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

4.  Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.

Authors:  S Silbert; A L Barth; H S Sader
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 5.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

6.  Rehabilitation Programs for Cystic Fibrosis - View from a CF Center.

Authors:  M Griese; P Busch; D Caroli; B Mertens; C Eismann; M Harari; H Staudter; M Kappler
Journal:  Open Respir Med J       Date:  2010-01-07

7.  Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.

Authors:  Mario Anthony; Barbara Rose; Mary Beard Pegler; Mark Elkins; Helen Service; Keerthi Thamotharampillai; Jason Watson; Michael Robinson; Peter Bye; John Merlino; Colin Harbour
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak.

Authors:  A M Jones; J R W Govan; C J Doherty; M E Dodd; B J Isalska; T N Stanbridge; A K Webb
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 9.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran.

Authors:  Z Movahedi; B Pourakbari; S Mahmoudi; F Sabouni; M T Ashtiani Haghi; R Hosseinpour Sadeghi; S Mamishi
Journal:  J Prev Med Hyg       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.